These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ultrastructural and biochemical alterations induced by 22,26-azasterol, a delta(24(25))-sterol methyltransferase inhibitor, on promastigote and amastigote forms of Leishmania amazonensis. Rodrigues JC; Attias M; Rodriguez C; Urbina JA; Souza Wd Antimicrob Agents Chemother; 2002 Feb; 46(2):487-99. PubMed ID: 11796362 [TBL] [Abstract][Full Text] [Related]
4. Modification of the sterol composition of Trypanosoma (Schizotrypanum) cruzi epimastigotes by delta 24(25)-sterol methyl transferase inhibitors and their combinations with ketoconazole. Urbina JA; Vivas J; Visbal G; Contreras LM Mol Biochem Parasitol; 1995 Jul; 73(1-2):199-210. PubMed ID: 8577328 [TBL] [Abstract][Full Text] [Related]
5. Effects of an azasterol inhibitor of sterol 24-transmethylation on sterol biosynthesis and growth of Leishmania donovani promastigotes. Haughan PA; Chance ML; Goad LJ Biochem J; 1995 May; 308 ( Pt 1)(Pt 1):31-8. PubMed ID: 7755579 [TBL] [Abstract][Full Text] [Related]
6. Antiproliferative effects of delta 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Urbina JA; Vivas J; Lazardi K; Molina J; Payares G; Piras MM; Piras R Chemotherapy; 1996; 42(4):294-307. PubMed ID: 8804798 [TBL] [Abstract][Full Text] [Related]
8. Inhibitors of sterol biosynthesis and amphotericin B reduce the viability of pneumocystis carinii f. sp. carinii. Kaneshiro ES; Collins MS; Cushion MT Antimicrob Agents Chemother; 2000 Jun; 44(6):1630-8. PubMed ID: 10817720 [TBL] [Abstract][Full Text] [Related]
9. Azasterol inhibitors in yeast. Inhibition of the 24-methylene sterol delta24(28)-reductase and delta24-sterol methyltransferase of Saccharomyces cerevisiae by 23-azacholesterol. Pierce HD; Pierce AM; Srinivasan R; Unrau AM; Oehlschlager AC Biochim Biophys Acta; 1978 Jun; 529(3):429-37. PubMed ID: 352402 [TBL] [Abstract][Full Text] [Related]
10. Evidence for the presence of "metabolic sterols" in Pneumocystis: identification and initial characterization of Pneumocystis carinii sterols. Kaneshiro ES; Ellis JE; Jayasimhulu K; Beach DH J Eukaryot Microbiol; 1994; 41(1):78-85. PubMed ID: 8124270 [TBL] [Abstract][Full Text] [Related]
11. Selective anti-Toxoplasma gondii activities of azasterols. Dantas-Leite L; Urbina JA; de Souza W; Vommaro RC Int J Antimicrob Agents; 2004 Jun; 23(6):620-6. PubMed ID: 15194134 [TBL] [Abstract][Full Text] [Related]
12. Sterol metabolism in the opportunistic pathogen Pneumocystis: advances and new insights. Kaneshiro ES Lipids; 2004 Aug; 39(8):753-61. PubMed ID: 15638243 [TBL] [Abstract][Full Text] [Related]
14. Sterol biosynthesis in Pneumocystis: unique steps that define unique targets. Kaneshiro ES Drug Resist Updat; 2002 Dec; 5(6):259-68. PubMed ID: 12531182 [TBL] [Abstract][Full Text] [Related]
15. Occurrence of specific sterols in Pneumocystis carinii. Florin-Christensen M; Florin-Christensen J; Wu YP; Zhou L; Gupta A; Rudney H; Kaneshiro ES Biochem Biophys Res Commun; 1994 Jan; 198(1):236-42. PubMed ID: 8292026 [TBL] [Abstract][Full Text] [Related]
16. C27 to C32 sterols found in Pneumocystis, an opportunistic pathogen of immunocompromised mammals. Kaneshiro ES; Wyder MA Lipids; 2000 Mar; 35(3):317-24. PubMed ID: 10783009 [TBL] [Abstract][Full Text] [Related]